Plus Therapeutics reported $-7.12M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Baxter International USD 276M 210M Jun/2026
Cerus USD -1.45M 488K Dec/2024
Dr.Reddys Laboratories INR 3.25B 2.36B Jun/2026
Haemonetics USD 57.46M 5.12M Jun/2026
Northwest Biotherapeutics USD -10.9M 3.42M Mar/2026
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Sanofi EUR 2.38B 449M Jun/2026
Starpharma Holdings AUD -873K 1.43M Dec/2025
Sun Pharmaceuticals INR 35.57B 8.05B Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026